All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

JAMA Study: Professionally Fitted Hearing Aids Outperform OTC Models, Though OTC Still Benefits Many Users

By

Karl Strom

5d ago· 7 min readenNews

Summary

A randomized clinical trial published in JAMA Otolaryngology-Head & Neck Surgery by researchers from the University of Iowa and Vanderbilt University found that hearing aids fitted by audiologists using best-practice prescription methods delivered better real-world outcomes for people with mild-to-moderate hearing loss compared to simulated over-the-counter (OTC) hearing aid models. However, the study also noted that OTC devices still provided generally positive results for many users, suggesting both options have value depending on individual needs and access to professional care.

Key quotes

· 3 pulled
New research from the University of Iowa and Vanderbilt University finds that best-practice prescription fittings yielded better real-world outcomes than simulated OTC hearing aid models, though OTC may still benefit many users.
A randomized clinical trial published May 15 in JAMA Otolaryngology-Head & Neck Surgery suggests that hearing aid users with mild-to-moderate hearing loss may get better real-world results when devices are fitted by audiologists using best practices
The study also found generally positive outcomes for over-the-counter (OTC) hearing aids.
Snippet from the RSS feed
JAMA study finds best-practice hearing aid fittings outperformed OTC-style care, though OTC devices still helped many users with mild-to-moderate hearing loss.

You might also wanna read

Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida

Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to

bit.ly·41m ago

Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1

Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus

biozentrum.unibas.ch·1h ago

Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation

A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.

bbc.co.uk·4h ago

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·5h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·6h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·6h ago